PFE and 0A3M Related Headlines
Go Back- Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
- Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
- Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
PFE and 0A3M Related Press Releases
Go Back- Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
- Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
- Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
